Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Microbot Medical Inc. - Common Stock (NQ: MBOT )

2.040 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 48,862
Open 2.040
Bid (Size) 2.010 (231)
Ask (Size) 2.040 (15)
Prev. Close 2.040
Today's Range 2.040 - 2.040
52wk Range 0.8200 - 3.380
Shares Outstanding 16,932,341
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Microbot Medical® Announces Late-Breaking Abstract Acceptance at the Society of Interventional Radiology Annual Meeting
Acceptance reflects the high interest of the SIR scientific committee on the emerging role of endovascular robotics 
From Microbot Medical Inc.
Via GlobeNewswire
Microbot Medical® Strengthens Its Management Team in Support of the Anticipated Commercial Launch of LIBERTY®
Operations Leader to Enhance Operational Efficiencies by Managing Production Scale-up and Cost Reduction Activities to Support Commercialization 
From Microbot Medical Inc.
Via GlobeNewswire

Performance

YTD
+78.95%
+78.95%
1 Month
-28.17%
-28.17%
3 Month
+116.01%
+116.01%
6 Month
+114.15%
+114.15%
1 Year
+70.00%
+70.00%

More News

Read More
Microbot Medical® Strengthens Its Commercial Capabilities with the Addition of David J. Wilson to the Board of Directors
From Microbot Medical Inc.
Via GlobeNewswire
Advanced Robotics Are Reshaping Medicine
Via News Direct
Microbot Medical Closes $8.6 Million Registered Direct Offering
From Microbot Medical Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Microbot Medical Announces $8.6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
From Microbot Medical Inc.
Via GlobeNewswire
Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM Facility
From Microbot Medical Inc.
Via GlobeNewswire
ChatGPT Moment For Robotics Is Around The Corner Says Nvidia CEO
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Microbot Medical (MBOT) Stock Is Up 22% Today
Via Benzinga
Microbot Medical Announces $7 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
From Microbot Medical Inc.
Via GlobeNewswire
US Stocks To Open Higher In Yet Another Truncated Week: Nvidia, Robotic Stocks In Focus Ahead Of CES 2025
Via Benzinga
Why Smart Share Global Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®
From Microbot Medical Inc.
Via GlobeNewswire
Palm-Sized Innovation: How Microbot Medical Is Helping Redefine Surgical Robotics
Via News Direct
Exposures Product Safety
Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access
From Microbot Medical Inc.
Via GlobeNewswire
Microbot Medical® Announces FDA Submission for the Commercialization of the LIBERTY® Endovascular Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
Global Medical Service Robotics Market Project to Exceed $20 Billion in 2024 with Additional Growth Expected
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025
From Microbot Medical Inc.
Via GlobeNewswire
Global Medical Service Robotics Market Project to Exceed $20 Billion in 2024 with Additional Growth Expected
From FN Media Group LLC
Via GlobeNewswire
Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up
From Microbot Medical Inc.
Via GlobeNewswire
Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System
From Microbot Medical Inc.
Via GlobeNewswire
Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
MBOT Stock Earnings: Microbot Medical Meets EPS for Q2 2024
Via InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.